Human miR-205 was used as a proof-of-concept miRNA due to its tumor-suppressive activity in the human prostate through the down-regulation of PRKCε (Protein kinase C epsilon type), and its expression is significantly reduced in PCa cell lines [151, 152]. The gene discussed is PRKCE; the disease is neoplasm.